Premium
COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE‐PLATINUM PLUS EGFR‐TKI VERSUS DOUBLE‐PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR‐TKI TREATMENT
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_83
Subject(s) - medicine , oncology , chemotherapy , adverse effect , platinum , disease , biochemistry , chemistry , catalysis